These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Cytochrome P450 2C19 polymorphism and clopidogrel after MI. Ramaraj R Lancet; 2009 Apr; 373(9670):1172; author reply 1172-3. PubMed ID: 19345827 [No Abstract] [Full Text] [Related]
16. Standard- vs high-dose clopidogrel after percutaneous coronary intervention. Jeong YH; Park Y; Kim IS JAMA; 2011 Jun; 305(24):2520; author reply 2521-2. PubMed ID: 21693737 [No Abstract] [Full Text] [Related]
17. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. Maeda A; Ando H; Asai T; Ishiguro H; Umemoto N; Ohta M; Morishima M; Sumida A; Kobayashi T; Hosohata K; Ushijima K; Fujimura A Clin Pharmacol Ther; 2011 Feb; 89(2):229-33. PubMed ID: 21178986 [TBL] [Abstract][Full Text] [Related]
18. Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit? Bhatt DL JAMA; 2009 Aug; 302(8):896-7. PubMed ID: 19706866 [No Abstract] [Full Text] [Related]